Back to Results
First PageMeta Content
Management of cancer / Cancer / Medicine / Drugs / Targeted therapy


NEWS RELEASE Foundation Medicine Expands Series B Financing to $56 Million Bill Gates, Evan Jones and Yuri Milner Join Existing Investors; Jones Appointed to the Board of Directors CAMBRIDGE, Mass., January 8, 2013 – F
Add to Reading List

Document Date: 2013-01-07 19:20:43


Open Document

File Size: 144,33 KB

Share Result on Facebook

Company

LabCorp / Kleiner Perkins Caufield & Byers / jVen Capital LLC / Redmile Group / Casdin Capital / Deerfield Management Company L.P. / Foundation Medicine Inc. / Third Rock Ventures / Digene Corporation / Google Ventures / Laboratory Corporation of America / founding investor Third Rock Ventures / /

Continent

America / /

Currency

USD / /

Event

Employment Change / /

IndustryTerm

care for cancer / cancer care / information technology / cancer treatment / genomic profiling and information services / cancer decision tools / healthcare / venture capital backers / /

MedicalCondition

tumor / cancer / disease / tumor DNA / solid tumor / solid tumors / human cancers / advanced cancer / diseases / traditional cancer / routine cancer / unique cancer / each patient’s unique cancer / /

Organization

WuXi Corporate Venture Fund / Roche Venture Fund / Board of Directors CAMBRIDGE / /

Person

Michael J. Pellini / Yuri Milner Join Existing / Bill Gates / Yuri Milner / Evan Jones / /

Position

co-founder / chairman and CEO / physician / president and chief executive officer / managing member / member of the board / /

Product

Series B / FoundationOne / FoundationOneTM / /

ProvinceOrState

Massachusetts / /

Technology

genomics / information technology / human genome / /

URL

www.FoundationMedicine.com / www.FoundationOne.com / /

SocialTag